HDFC Pharma and Healthcare Fund vs Tata India Pharma & Healthcare Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Fund | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹2011 Cr | ₹1339 Cr |
| Min Investment | ₹100 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹100 |
| Min Addl Investment | ₹100 | ₹1000 |
| Launch Date | 04 Oct 2023 | 28 Dec 2015 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare Index | Nifty Pharma TRI |
| Turn Over | % | 26.49% |
| Expense Ratio | 2.14 | 2.14 |
| Manager | Dhruv Muchhal | Meeta Shetty |
| ISIN Code | INF179KC1HL7 | INF277K016A9 |
| Exits Load | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Month | -0.66% | -1.03% |
| 6 Month | 3.17% | 0.71% |
| 1 Year | 1.1% | -5.13% |
| 3 Year | - | 22.51% |
| 5 Year | - | 14.78% |
SIP Return Analysis
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 6 Month | 0.36% | -0.89% |
| 1 Year | 9.96% | 4.55% |
| 3 Year | - | 16.19% |
| 5 Year | - | 16.27% |
Rolling Lumpsum Returns
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Year | 27.59% | 8.03% |
| 3 Year | - | 18.91% |
| 5 Year | - | 15.62% |
Risk Management
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Standard Deviation | - | 14.23% |
| Sharp | - | 0.96% |
| Beta | - | 0.92% |
| Alpha | - | 1.83% |
Fund Managers
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Name | Dhruv Muchhal | Meeta Shetty |
| Total AUM | ₹520687 Cr | ₹17847 Cr |
| Funds Managed | 40 | 5 |
| HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 1.61 | 5 |
| Small Cap | 32.62 | 38.83 |
| Large Cap | 38.75 | 36.53 |
| Mid Cap | 27.02 | 19.64 |
Sector Allocation
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 1.61 | 5 |
| Pharmaceuticals & Biotechnology | 75.22 | 55.19 |
| Healthcare Services | 22.28 | 35.64 |
| Healthcare Equipment & Supplies | 0.89 | 0.03 |
| Fertilizers & Agrochemicals | - | 4.14 |
Top Comparisons
Sundaram Short Duration Fund Regular Growth
3Y Returns7.34%
Axis Short Duration Fund - Regular Plan - Growth Option
3Y Returns7.6%
INVESCO INDIA ULTRA SHORT DURATION FUND - Growth
3Y Returns6.96%
PGIM India Ultra Short Duration Fund - Growth
3Y Returns6.56%
WhiteOak Capital Mid Cap Fund Regular Plan Growth
3Y Returns25.87%
Nippon India Growth Mid Cap Fund-Growth Plan-Growth Option
3Y Returns25.32%
Franklin India Conservative Hybrid Fund - Growth
3Y Returns9.4%
Franklin India Conservative Hybrid Fund - Growth
3Y Returns9.4%